Your browser doesn't support javascript.
loading
Population Pharmacokinetics and Exposure-Response Modeling of Daratumumab Subcutaneous Administration in Patients With Light-Chain Amyloidosis.
Luo, Man Melody; Zhu, Peijuan Penny; Nnane, Ivo; Xiong, Yuan; Merlini, Giampaolo; Comenzo, Raymond L; Kastritis, Efstathios; Wechalekar, Ashutosh D; Weiss, Brendan M; Tran, NamPhuong; Qin, Xiang; Vermeulen, Jessica; Sharma, Amarnath; Sun, Yu-Nien; Zhou, Honghui.
Afiliação
  • Luo MM; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Zhu PP; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Nnane I; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Xiong Y; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Merlini G; Amyloidosis Research and Treatment Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Comenzo RL; Division of Hematology/Oncology, John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, Massachusetts, USA.
  • Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Wechalekar AD; University College London, London, UK.
  • Weiss BM; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Tran N; Janssen Research & Development, Los Angeles, California, USA.
  • Qin X; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Vermeulen J; Janssen Research & Development, Leiden, The Netherlands.
  • Sharma A; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Sun YN; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Zhou H; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
J Clin Pharmacol ; 62(5): 656-669, 2022 05.
Article em En | MEDLINE | ID: mdl-34708423

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Amiloidose / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Clin Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Amiloidose / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Clin Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos